Taher, Ali T.

Thalassaemia

Taher, A. T., Weatherall, D. J., & Cappellini, M. D. (2018) · The Lancet

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 807

Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management

Cappellini, M. D., Comin‐Colet, J., de Francisco, A., Dignass, A., Doehner, W., Lam, C. S., Macdougall, I. C., Rogler, G., Camaschella, C., Kadir, R., et al. (2017) · American Journal of Hematology

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 502

A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia.

Cappellini, M. D., Viprakasit, V., Taher, A. T., Georgiev, P., Kuo, K. H. M., Coates, T., Voskaridou, E., Liew, H.-K., Pazgal-Kobrowski, I., Forni, G. L., et al. (2020) · New England Journal of Medicine

Hemoglobinopathies and Related DisordersBlood transfusion and management

Cited by 332

Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia.

Musallam, K. M., Sankaran, V. G., Cappellini, M. D., Duca, L., Nathan, D. G., & Taher, A. T. (2012) · Blood

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 103

Iron overload in β-thalassemia intermedia: an emerging concern

Musallam, K. M., Cappellini, M. D., & Taher, A. T. (2013) · Current Opinion in Hematology

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 50

Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common α-thalassemia point mutations and deletions

Puehringer, H., Najmabadi, H., Law, H.-Y., Krugluger, W., Viprakasit, V., Pissard, S., Baysal, E., Taher, A., Farra, C., Al-Ali, A., et al. (2007) · Clinical Chemical Laboratory Medicine

Hemoglobinopathies and Related DisordersBlood groups and transfusion

Cited by 45